儿童和年轻成人对2019-20年细胞培养灭活与鸡胚培养减毒流感疫苗抗体应答的随机对照试验
研究将4-21岁参与者随机分配接种ccIIV4(n=100)或LAIV4(n=98),比较2019-2020流感疫苗的血凝抑制抗体应答。ccIIV4组几何平均 fold rise 较LAIV4组高2.4-3.0倍(p<0.001),两种疫苗的接种前抗体滴度均反向预测几何平均 fold rise。
要点
- ccIIV4组的几何平均 fold rise 较LAIV4组高2.4-3.0倍(p<0.001)。
- 两种疫苗对A/H1N1、A/H3N2和B/Victoria的几何平均滴度均升高,ccIIV4还使B/Yamagata升高。
- 接种前血凝抑制抗体滴度反向预测几何平均 fold rise,两种疫苗均如此。
核心结论
- 在主要为较大儿童的研究中,ccIIV4的血凝抑制抗体应答强于LAIV4,且两种疫苗的接种前血凝抑制抗体滴度均反向预测几何平均 fold rise。
研究设计与样本
- 随机对照试验,4-21岁参与者按1:1随机接受ccIIV4(n=100)或LAIV4(n=98),接种前和接种后第28天(21-35天)采血。
主要发现
- ccIIV4组几何平均 fold rise 较LAIV4组高2.4-3.0倍(p<0.001)。
- 接种后第28天,ccIIV4组鸡胚培养A/H3N2几何平均滴度为205(95%CI:178-237),细胞培养A/H3N2为136(95%CI:113-165)。
- 接种后第28天,LAIV4组鸡胚培养A/H3N2几何平均滴度为96(95%CI:83-112),细胞培养A/H3N2为63(95%CI:58-74)。
- 两种疫苗对A/H1N1、A/H3N2和B/Victoria的几何平均滴度均升高(p<0.05),ccIIV4还使B/Yamagata几何平均滴度升高(p<0.05)。
- A/H3N2细胞培养和鸡胚培养抗原的几何平均 fold rise 相似,接种前滴度反向预测几何平均 fold rise。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hemagglutination inhibition (HAI) titers to the live-attenuated influenza vaccine (LAIV4) are typically lower than its counterpart egg-based inactivated influenza vaccines (IIV). Similar comparisons have not been made between LAIV4 and the 4-strain, cell-culture inactivated influenza vaccine (ccIIV4). We compared healthy children's and young adults' HAI titers against the 2019-2020 LAIV4 and ccIIV4. METHODS: Participants aged 4-21 years were randomized 1:1 to receive ccIIV4 (n = 100) or LAIV4 (n = 98). Blood was drawn prevaccination and on day 28 (21-35) post vaccination. HAI assays against egg-grown A/H1N1, A/H3N2, both vaccine B strains and cell-grown A/H3N2 antigens were conducted. Primary outcomes were geometric mean titers (GMT) and geometric mean fold rise (GMFR) in titers. RESULTS: GMTs to A/H1N1, A/H3N2 and B/Victoria increased following both ccIIV and LAIV and to B/Yamagata following ccIIV (p < 0.05). The GMFR range was 2.4-3.0 times higher for ccIIV4 than for LAIV4 (p < 0.001). Within vaccine types, egg-grown A/H3N2 GMTs were higher (p < 0.05) than cell-grown GMTs [ccIIV4 day 28: egg = 205 (95% CI: 178-237); cell = 136 (95% CI:113-165); LAIV4 day 28: egg = 96 (95% CI: 83-112); cell = 63 (95% CI: 58-74)]. The GMFR to A/H3N2 cell-grown and egg-grown antigens were similar. Pre-vaccination titers inversely predicted GMFR. CONCLUSION: The HAI response to ccIIV4 was greater than LAIV4 in this study of mostly older children, and day 0 HAI titers inversely predicted GMFR for both vaccines. Lower prevaccination titers were associated with greater GMFR in both vaccine groups.
引用
- Williams KV, Zhai B, Alcorn JF, et al. A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults. Vaccine. 2021. PMID: 34952751. doi:10.1016/j.vaccine.2021.12.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。